Alkermes plc Overview
Alkermes plc (ALKS) has a P/E ratio of 121.56, above the Healthcare sector average of 27.42.
Get informed when a big investor buys or sells
+ Follow121.56
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Alkermes plc's p/e ratio stands at 121.56. That is above the Healthcare sector average of 27.42. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Alkermes plc sits higher the Healthcare benchmark (27.42) with a P/E ratio of 121.56. That is roughly 343.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 121.56 is attractive depends on Alkermes plc's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Alkermes plc's P/E ratio evolved across reporting periods, while the comparison chart places ALKS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Alkermes plc's reading of 121.56 (sector avg 27.42) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
